Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
Abstract Fibrotic diseases cause organ failure that lead to ~45% of all deaths in the United States. Activated macrophages stimulate fibrosis by secreting cytokines that induce fibroblasts to synthesize collagen and extracellular matrix proteins. Although suppression of macrophage‐derived cytokine p...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Nature
2020-06-01
|
| Col·lecció: | EMBO Molecular Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.15252/emmm.202012034 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
